BioNxt Solutions Inc.
BNXTF
$0.46
$0.024.07%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -34.40% | -- | -- | -77.08% | 190.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.40% | -- | -- | -77.08% | 190.70% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -34.40% | -- | -- | -77.08% | 190.70% |
| SG&A Expenses | 34.45% | 79.12% | 80.43% | -17.83% | 60.48% |
| Depreciation & Amortization | -76.33% | -70.66% | -123.84% | -48.42% | -53.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.32% | 49.05% | 27.96% | -47.33% | 21.06% |
| Operating Income | 4.93% | -49.28% | -28.36% | 47.04% | -20.16% |
| Income Before Tax | -8.34% | -31.98% | -17.86% | 45.29% | -2.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.34% | -31.98% | -17.86% | 48.84% | -2.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.34% | -31.98% | -17.86% | 48.84% | -2.67% |
| EBIT | 4.93% | -49.28% | -28.36% | 47.04% | -20.16% |
| EBITDA | 3.67% | -53.22% | -28.98% | 47.84% | -23.60% |
| EPS Basic | -4.21% | -24.62% | -11.21% | 52.33% | 10.38% |
| Normalized Basic EPS | -1.69% | -21.95% | -2.99% | 39.78% | 10.61% |
| EPS Diluted | -4.21% | -24.62% | -11.21% | 52.33% | 10.38% |
| Normalized Diluted EPS | -1.69% | -21.95% | -2.99% | 39.78% | 10.61% |
| Average Basic Shares Outstanding | 4.09% | 5.77% | 5.86% | 7.41% | 14.37% |
| Average Diluted Shares Outstanding | 4.09% | 5.77% | 5.86% | 7.41% | 14.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |